q2fy17 investor presentation chairman s agm 2016 speech annual reports facilities virtual tour downloads biocon profile cmd profile video gallery annual report 2016 biocon malaysia biocon academy email admissions bioconacademy.com at biocon we are driven by our passion to develop research driven cutting edge biopharmaceuticals to address the relatively unmet needs of patients suffering from chronic diseases such as cancer diabetes and autoimmune conditions . our commitment to impact global health has led us to build differentiated capabilities in the areas of biologics and complex small molecules . we have used advanced technology platforms to develop and deliver a rich portfolio of generic small molecule apis and formulations novel biologics and biosimilars including monoclonal antibodies rh insulin and analogs . we believe our value proposition built around differentiation and scale has enabled us to seek global leadership to provide access to affordable biopharmaceuticals for patients and partners across the globe . we are constantly engaged in pursuit of excellence to develop high quality safe and efficacious products that can heal the world . read more ... q1fy17 highlights stock update latest press release sept. 19 2016 biocon appoints suresh subramanian as head of branded formulations india business sept. 01 2016 kiran mazumdar shaw appointed knight of the legion of honour by the government of france aug. 25 2016 mylan and biocon announce regulatory submission for proposed biosimilar trastuzumab accepted for review by european medicines agency media coverage october 2016 biocon gears up to launch new drugs to treat diabetes cancer september 2016 top french honour for biocon s kiran shaw august 2016 we have enhanced patient access to insulin across india kiran mazumdar shaw july 2016 we need meritocracy not mediocrity kiran mazumdar shaw contact contact contact contact biocon businesses recommended sites biocon on home about us investor relations media relations careers site map contact us our growth accelerators fact sheet branded formulations biopharmaceuticals research services active discovery program able karnataka vision group on bt syngene international biocon academy report adverse event side effects and product complaints disclaimer 2016 biocon . all rights reserved